anti-HER3/topoisomerase I inhibitor antibody-drug conjugate
Term · Oncology and biomedicine · MLC-T-ONC-010779
Any antibody-drug conjugate (ADC) that is composed of a monoclonal antibody directed against human epidermal growth factor receptor 3 (HER3; ErbB3) and conjugated to a cytotoxic DNA topoisomerase I inhibitor.
| Identifier | MLC-T-ONC-010779 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-HER3/Top-I inhibitor ADC; anti-HER3/TopIi ADC; anti-HER3/topoisomerase I inhibitor ADC |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010779",
"term": "anti-HER3/topoisomerase I inhibitor antibody-drug conjugate",
"field": "Oncology and biomedicine",
"definition": "Any antibody-drug conjugate (ADC) that is composed of a monoclonal antibody directed against human epidermal growth factor receptor 3 (HER3; ErbB3) and conjugated to a cytotoxic DNA topoisomerase I inhibitor.",
"synonyms": [
"anti-HER3/Top-I inhibitor ADC",
"anti-HER3/TopIi ADC",
"anti-HER3/topoisomerase I inhibitor ADC"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-her3-topoisomerase-i-inhibitor-antibody-drug-conjugate/"
}
Record 1,887 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.